Visterra hooks Pfizer with pan-influenza anti-HA MAb
11:08 EDT 11 Sep 2012 | SCRIP
Cambridge, Massachusetts-based Visterra isn't exactly a startup, since that has already raised over $22 million in seed and venture capital since its foundation in 2007. But the small biotechnology firm is coming out of stealth mode with its first Bi..
Original Article: Visterra hooks Pfizer with pan-influenza anti-HA MAb
More From BioPortfolio on "Visterra hooks Pfizer with pan-influenza anti-HA MAb"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
